SOX15, as a transcription factor, has been widely demonstrated to inhibit tumor growth through the Wnt/β-catenin pathway [11–13] and to function with miR-96 to regulate androgen receptor signals during prostate cancer progression [14]. Here, SOX15 is linked to prostate carcinoma.